Form 10-K/A Altisource Asset Managem For: Dec 31
http://archive.fast-edgar.com/20240429/A2LZ222CZ222S2Z2222E22ZAPNPNZJ227D62
Filed on: April 29, 2024
Form 8-K CPS TECHNOLOGIES CORP/DE For: Apr 25
false
0000814676
0000814676
2024-04-25
2024-04-25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 25, 2024
CPS TECHNOLOGIES CORP.
(Exact Name of Registrant as Specified in its... (continue reading...)
Form 8-K Scorpius Holdings, Inc. For: Apr 29
false
0001476963
0001476963
2024-04-29
2024-04-29
0001476963
us-gaap:CommonStockMember
2024-04-29
2024-04-29
0001476963
SCPX:CommonStockPurchaseRightsMember
2024-04-29
2024-04-29
iso4217:USD
... (continue reading...)
Form 6-K Valens Semiconductor For: Apr 29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
Commission File Number: 001-40842
VALENS SEMICONDUCTOR LTD.
(Exact name of registrant as specified in its charter)
8 Hanagar St. POB 7152
Hod Hasharon 4501309
Israel
(Address of principal executive office)
More SEC Filings
View Older Stories-
Form 485BPOS DAVIS SERIES INC
-
Form 8-K OGLETHORPE POWER CORP For: Apr 29
-
Form 8-K ON SEMICONDUCTOR CORP For: Apr 29
-
Form 10-D World Omni Automobile For: Mar 31
-
Form ARS Carisma Therapeutics For: Dec 31
-
Form D/A Lantah Co
-
Form DEFA14A Vital Farms, Inc.
-
Form 20-F Tuniu Corp For: Dec 31
-
Form 8-K COLLEGIUM PHARMACEUTICAL For: Apr 26
-
Form DEFA14A C4 Therapeutics, Inc.
-
Form 425 UMB FINANCIAL CORP Filed by: UMB FINANCIAL CORP
-
Form 10-Q NEWMONT Corp /DE/ For: Mar 31
-
Form 497K JNL SERIES TRUST
-
Form 10-K Namliong SkyCosmos, Inc. For: Dec 31
-
Form 6-K DAQO NEW ENERGY CORP. For: Apr 29
-
Form DEF 14A C4 Therapeutics, Inc. For: Apr 29
-
Form ARS Compass Therapeutics, For: Dec 31
-
Form DEF 14A Carisma Therapeutics For: Jun 13
-
Form 497K T. Rowe Price Equity
-
Form 497 T. Rowe Price Equity
-
Form 425 California BanCorp Filed by: Southern California Bancorp \ CA
-
Form DEFA14A Compass Therapeutics,
-
Form 8-K California BanCorp For: Apr 29
-
Form 20-F SunCar Technology Group For: Dec 31
-
Form ARS NOVAVAX INC For: Dec 31
-
Form DEF 14A Vital Farms, Inc. For: Jun 12
-
Form 1-K Sugarfina Corp For: Dec 31
-
Form 8-K Southern California Banc For: Apr 29
-
Form 6-K Enlivex Therapeutics For: Apr 29
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 8-K UMB FINANCIAL CORP For: Apr 28
-
Form NT 20-F First High-School Educat For: Dec 31
-
Form 8-K Auto Parts 4Less Group, For: Apr 29
-
Form 8-K Aclarion, Inc. For: Apr 26
-
Form 8-K ALLIANCE RESOURCE PARTNE For: Apr 29
-
Form 10-K/A CBAK Energy Technology, For: Dec 31
-
Form 8-K Innovative Eyewear Inc For: Apr 28
-
Form 8-K Mosaic ImmunoEngineering For: Apr 26
-
Form 8-K Ocugen, Inc. For: Apr 26
-
Form DEF 14A Plymouth Industrial REIT For: Jun 27
-
Form 8-K QuidelOrtho Corp For: Apr 25
-
Form DEF 14A Compass Therapeutics, For: Jun 13
-
Form 6-K Baijiayun Group Ltd For: Apr 29
-
Form 8-K White River Energy Corp. For: Apr 29
-
Form S-3ASR International Seaways,
-
Form DEFA14A NOVAVAX INC
-
Form D Granular Fund Ltd
-
Form 8-K IMPERIAL OIL LTD For: Apr 29
-
Form 6-K Kanzhun Ltd For: Apr 29
-
Form 10-D World Omni Automobile For: Mar 31